Search Within

Charles Rudin

Formats
  1. Journal Article (243)
  2. Meeting Abstract (223)
  3. Review (11)
  4. Editorial (10)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (495)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (495)
  3. Department of Medicine (495)
  4. GSK Faculty (495)
  5. Solid Tumor Oncology Division (495)
  6. Thoracic Oncology (495)

More Groups

People
  1. Mark Kris (100)
  2. Natasha Rekhtman (96)
  3. Marc Ladanyi (93)
  4. Gregory Riely (76)
  5. Bob Li (72)
  6. Elisa De Stanchina (70)

More People

Years
  1. 2025 (18)
  2. 2024 (48)
  3. 2023 (43)
  4. 2022 (59)
  5. 2021 (52)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Journal of Thoracic Oncology (79)
  3. Clinical Cancer Research (33)
  4. Cancer Research (31)
  5. Annals of Oncology (30)
  6. Cancer Discovery (15)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. American Society of Clinical Oncology (93)
  3. American Association for Cancer Research (86)
  4. Nature Publishing Group (45)
  5. Oxford University Press (40)
  6. Cell Press (28)

More Publishers

Results (495)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting LSD1 rescues MHC-I antigen presentation and overcomes resistance to PD-L1 blockade therapy in small cell lung cancer
    Meeting Abstract

    Nguyen, E.; Chow, A.; Rudin, C.; Sen, T.; Taniguchi, H.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) ± tremelimumab (T) + platinumetoposide (EP) in extensive-stage small-cell lung cancer (ES–SCLC): RNA sequencing analysis to explore canonical markers of IO activity in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; O'Brien, C.; Lai, Z.; Stewart, R.; Paz-Ares, L.; Goldman, J.; Garassino, M.; Rudin, C.; Barrett, J. C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Small cell lung cancer molecular subtypes and vulnerability to immune checkpoint blockade
    Meeting Abstract

    Nabet, B.; Hamidi, H.; Banchereau, R.; Morris, S.; Adler, L.; Srivastava, M.; Patil, N.; Gay, C.; Minna, J.; Heymach, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers
    Meeting Abstract

    Rothwell, D. G.; Chemi, F.; Pearce, S.; Clipson, A.; Hill, S.; Conway, A. M.; Richardson, S.; Murat, K.; Caeser, R.; Egger, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ferroptosis evasion as a therapeutic strategy in STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Durani, V.; Wohlhieter, C. A.; Quintanal-Villalonga, A.; Sen, T.; Manoj, P.; Rudin, C. M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response
    Meeting Abstract

    Rosen, M.; Amar, D.; Winters, I.; Rizvi, H.; Nie, W.; Wall, G.; Petrov, D.; Winslow, M.; Rudin, C.; Juan, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save